Acute kidney injury in an older patient

Clinical record

Correspondence: Bobby.Chacko@hnehealth.nsw.gov.au

Competing interests:

No relevant disclosures.

1. Therapeutic Goods Administration. Piperacillin sodium – medicine shortage information. http://apps.tga.gov.au/Prod/msi/Search/Details/piperacillin-sodium (viewed Sept 2018).
2. Rutter WC, Cox JN, Martin CA, et al. Nephrotoxicity during vancomycin therapy in combination with piperacillin–tazobactam or cefepime. Antimicrob Agents Chemother 2017; 61: 1-9.
3. Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis, 1993–2011: a case series. Am J Kidney Dis 2014; 64: 558-566.
4. Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int 2010; 77: 956-961.
5. Raghavan R, Eknoyan G. Acute interstitial nephritis – a reappraisal and update. Clin Nephrol 2014; 82: 149-162.
6. Mac K, Chavada R, Paull S, Howlin K, Wong J. Cefepime induced acute interstitial nephritis – a case report. BMC Nephrol 2015; 16: 15.
7. Alzubaidi M SS, Velez JC. Acute interstitial nephritis with cast formation associated with exposure to cefepime [abstract]. Am J Kidney Dis 2016; 67: A1-A118.
8. Perazella MA. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol 2014; 81: 381-388.

Online responses are no longer available. Please refer to our instructions for authors page for more information.